GCG and Hypoglycemia: Numerous studies have highlighted the distinctive benefits of GLP-1 RAs in diabetes management, showcasing a reduced risk of hypoglycemia, the capacity to restore β-cell function, and the potential to enhance cardiovascular outcomes, particularly in high-risk populations (4, 5).